DIEBOLD NIXDORF, Inc(DBD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,717 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
DBD Stock Analysis & AI Quality Score
AI stock analysis and institutional research for DIEBOLD NIXDORF, Inc (DBD), a Technology sector company. 13F Pro's AI-powered ranking engine scores DBD at 45.4/100 on a 32-signal composite quality model, placing it at rank #1,717 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (30.0) and earnings quality (30.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), DIEBOLD NIXDORF, Inc reports quarterly revenue of $891.8M, net income of $5.0M, an operating margin of 3.7%. Top institutional holders of DBD by reported 13-F value include Capital World Investors, Millstreet Capital Management, BlackRock,, based on the most recent SEC filings. DBD trades on the NYSE exchange and files with the SEC under CIK 28823. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DBD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DIEBOLD NIXDORF, Inc directly from SEC EDGAR. DIEBOLD NIXDORF, Inc's 13F Pro composite quality score has ranged between 8 and 62 since 2021, currently 45.4 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$891.8M
Net Income
Q1 2026
$5.0M
Free Cash Flow
Q1 2026
$31.7M
Operating Margin
Q1 2026
3.7%
ROIC
Q1 2026
1.7%
D/E Ratio
Q1 2026
0.95
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-11.4% YoYNet Income
-637.8% YoYOperating Income
-254.4% YoYEPS (Diluted)
-628.7% YoYTotal Assets
-12.6% YoYTotal Debt
+15.1% YoYOp. Cash Flow
-414.6% YoY| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2010 |
|---|---|---|---|---|---|---|
| Revenue | $3.46B -11.4% | $3.91B +0.1% | $3.90B -11.5% | $4.41B -3.7% | $4.58B +62.1% | $2.82B |
| Net Income | $-581.4M -637.8% | $-78.8M +70.7% | $-269.1M +21.2% | $-341.3M +35.8% | $-531.4M -2523.9% | $-20.3M |
| Operating Income | $-211.7M -254.4% | $137.1M +471.3% | $24.0M +190.2% | $-26.6M +91.8% | $-325.6M -17968.8% | $-1.8M |
| EPS (Diluted) | $-7.36 -628.7% | $-1.01 +70.9% | $-3.47 | — | $-7.48 -2312.9% | $-0.31 |
| Total Assets | $3.06B -12.6% | $3.51B -4.1% | $3.66B -3.5% | $3.79B -12.1% | $4.31B +71.1% | $2.52B |
| Total Debt | $2.59B +15.1% | $2.25B -3.9% | $2.34B +10.8% | $2.11B -3.7% | $2.19B +297.9% | $550.4M |
| Operating Cash Flow | $-387.9M -414.6% | $123.3M +585.0% | $18.0M -86.7% | $135.8M +230.5% | $-104.1M -138.1% | $273.4M |
AI Insight: DBD Financial Trends
Revenue volatility persists with Q1 2026 dropping 19% sequentially to $892M despite Q4 2025 hitting $1.1B peak.
• Operating income improved from $30M in Q1 2025 to $33M in Q1 2026, though well below Q4 2025's $82M.
• Total debt decreased from $1,100M in Q2 2024 to $970M in Q1 2026, reducing leverage.
• Operating cash flow turned positive, reaching $32M in Q1 2026 versus negative $8M in Q2 2024.
⚠ Quarterly revenue swings remain extreme, ranging from $841M to $1,104M over the past eight quarters.
⚠ Equity declined to $1,023M in Q1 2026 from $1,107M in Q3 2025 after recent gains.
AI Insight: DBD Ratio Trends
DBD's profitability collapsed in Q1 2026 with operating margin dropping from 7.5% to 3.7% after strong Q3-Q4 2025 performance.
• Operating margin declined sharply from 7.5% in Q4 2025 to 3.7% in Q1 2026, erasing prior quarter gains.
• ROIC fell from 15.9% in Q4 2025 to 6.6% in Q1 2026, marking a significant retreat from recent highs.
• Net profit margin compressed to 0.6% in Q1 2026 from 4.5% in Q4 2025, indicating profitability pressures.
• Debt-to-equity ratio improved from 1.10 in Q2 2024 to 0.95 in Q1 2026, showing gradual deleveraging.
⚠ Q1 seasonal weakness appears severe — monitor if this is normal pattern or structural deterioration.
⚠ ROIC volatility between 6.1% and 15.9% over recent quarters suggests inconsistent capital efficiency.
Get alerted when DBD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for DIEBOLD NIXDORF, Inc including:
Top Institutional Holders of DBD
Capital World Investors
$875.3M11,602,095 shMillstreet Capital Management LLC
$393.5M5,216,672 shBlackRock, Inc.
$150.5M1,995,296 shWILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
$107.6M1,426,464 shDIMENSIONAL FUND ADVISORS LP
$86.7M1,148,962 shVANGUARD CAPITAL MANAGEMENT LLC
$84.7M1,122,229 shGEODE CAPITAL MANAGEMENT, LLC
$63.4M839,721 shBeach Point Capital Management LP
$60.4M800,661 shAMERICAN CENTURY COMPANIES INC
$56.0M742,736 shAllspring Global Investments Holdings, LLC
$52.1M670,414 sh
| Fund | Value | Shares |
|---|---|---|
| Capital World Investors | $875.3M | 11,602,095 |
| Millstreet Capital Management LLC | $393.5M | 5,216,672 |
| BlackRock, Inc. | $150.5M | 1,995,296 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $107.6M | 1,426,464 |
| DIMENSIONAL FUND ADVISORS LP | $86.7M | 1,148,962 |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.7M | 1,122,229 |
| GEODE CAPITAL MANAGEMENT, LLC | $63.4M | 839,721 |
| Beach Point Capital Management LP | $60.4M | 800,661 |
| AMERICAN CENTURY COMPANIES INC | $56.0M | 742,736 |
| Allspring Global Investments Holdings, LLC | $52.1M | 670,414 |
More Technology Companies
View all Technology →Put DBD on your watchlist
Track score changes the day DIEBOLD NIXDORF, Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is DBD a good stock to buy?
13F Pro's AI-powered analysis of DIEBOLD NIXDORF, Inc (DBD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DBD are available on the DBD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own DBD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DBD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DIEBOLD NIXDORF, Inc's investment landscape.